DEZ-001: Completed Phase IIb enrollment

Dezima completed enrollment of 360 patients with mild dyslipidemia in the double-blind, placebo-controlled, dose-ranging, European Phase IIb TULIP trial evaluating oral DEZ-001 alone and in combinatio...